Financial statements Plus Solinea Pharma

Balance sheet of Plus Solinea Pharma

Company age:
Age:
7 y. 1 m. 28 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of PLUS SOLINEA PHARMA

Year
2020
2021
2022
2023
Total assets 104 593,70 104 172,52 191 698,00 487 855,29
A. Fixed assets 0,00 0,00 0,00 0,00
B. Current assets 104 593,70 104 172,52 191 698,00 487 855,29
C. Share capital contributions (basic funds) 0,00 0,00 - -
D. Own shares (stocks) 0,00 0,00 - -
Total liabilities 104 593,70 104 172,52 191 698,00 487 855,29
A. Equity -159 852,43 -143 868,40 -234 483,45 -189 629,93
B. Liabilities and provisions for liabilities 264 446,13 248 040,92 426 181,45 677 485,22
I. Long-term liabilities 118 017,60 0,00 - -
II. Short-term liabilities 146 428,53 248 040,92 389 781,45 644 385,22
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.